Literature DB >> 2274933

The role of platelet-activating factor in endothelial cells.

S M Prescott1, T M McIntyre, G A Zimmerman.   

Abstract

Endothelial cells activated by receptor-mediated agonists, particularly those involved in inflammation and thrombosis, synthesize platelet-activating factor and express it on their surfaces. This PAF serves as a signal for neutrophils, and perhaps other blood cells, to bind to the endothelium. In some cases, the PAF produced by endothelial cells appears to be a sufficient stimulus for this binding, but in other circumstances it appears to act in concert with a glycoprotein, GMP-140. The synthesis and expression of PAF are tightly regulated under normal conditions, but can be induced by bacterial toxins and oxidants, which in vivo might result in vascular damage and thrombosis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2274933

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  Neutrophil adhesion to human endothelial cells is induced by the membrane attack complex: the roles of P-selectin and platelet activating factor.

Authors:  K S Kilgore; P A Ward; J S Warren
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

2.  Release of histamine in whole blood by oxygen radicals: division between specific and unspecific processes.

Authors:  B Poch; F Gansauge; S Gansauge; T Anger; U Nilsson; M H Schoenberg; H G Beger
Journal:  Inflamm Res       Date:  1996-08       Impact factor: 4.575

3.  Human platelets release a paf-acether: acetylhydrolase similar to that in plasma.

Authors:  R Korth; J Bidault; R Palmantier; J Benveniste; E Ninio
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

4.  Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart.

Authors:  G Montrucchio; G Alloatti; F Mariano; A Comino; G Cacace; R Polloni; P G De Filippi; G Emanuelli; G Camussi
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

5.  Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats.

Authors:  Caroline Bélanger; Hanan Elimam; Julie Lefebvre; Pierre Borgeat; Sylvie Marleau
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

6.  S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.

Authors:  R Heller; F Bussolino; R Calvino; D Ghigo; P Alessio; R Todde; R Fruttero; G Pescarmona; A Gasco; U Till
Journal:  Agents Actions       Date:  1993-11

7.  Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells.

Authors:  V Gebuhrer; J F Murphy; J C Bordet; M P Reck; J L McGregor
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

Review 8.  Understanding the connection between platelet-activating factor, a UV-induced lipid mediator of inflammation, immune suppression and skin cancer.

Authors:  Elisabetta Damiani; Stephen E Ullrich
Journal:  Prog Lipid Res       Date:  2016-04-09       Impact factor: 16.195

Review 9.  Role of histamine and platelet-activating factor in allergic rhinitis.

Authors:  V Alfaro
Journal:  J Physiol Biochem       Date:  2004-06       Impact factor: 5.080

10.  YY-1224, a terpene trilactone-strengthened Ginkgo biloba, attenuates neurodegenerative changes induced by β-amyloid (1-42) or double transgenic overexpression of APP and PS1 via inhibition of cyclooxygenase-2.

Authors:  Zheng-Yi Li; Yoon Hee Chung; Eun-Joo Shin; Duy-Khanh Dang; Ji Hoon Jeong; Sung Kwon Ko; Seung-Yeol Nah; Tae Gon Baik; Jin Hyeong Jhoo; Wei-Yi Ong; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  J Neuroinflammation       Date:  2017-04-27       Impact factor: 8.322

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.